pemoline has been researched along with Anxiety Disorders in 3 studies
Pemoline: A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children.
pemoline : A member of the class of 1,3-oxazoles that is 1,3-oxazol-4(5H)-one which is substituted by an amino group at position 2 and by a phenyl group at position 5. A central nervous system stimulant, it was used to treat hyperactivity disorders in children, but withdrawn from use following reports of serious hepatotoxicity.
Anxiety Disorders: Persistent and disabling ANXIETY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pemoline was associated with a significant decrease in the high frequency (HF) power (0." | 2.71 | Effect of fluoxetine, pemoline and placebo on heart period and QT variability in normal humans. ( Balon, R; Doll, RG; Jayaraman, A; Pohl, R; Yeragani, V, 2003) |
| "Pemoline was given orally in increasing doses ranging from 20 to 80 mg/day." | 1.27 | EEG and clinical findings during pemoline treatment in children and adults with attention deficit disorder. An 8-week open trial. ( Barteselli, F; Besana, R; Caresia, L; Guareschi Cazzullo, A; Musetti, L; Pugnetti, L; Scarone, S, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marcus, SC | 1 |
| Durkin, M | 1 |
| Pohl, R | 1 |
| Balon, R | 1 |
| Jayaraman, A | 1 |
| Doll, RG | 1 |
| Yeragani, V | 1 |
| Caresia, L | 1 |
| Pugnetti, L | 1 |
| Besana, R | 1 |
| Barteselli, F | 1 |
| Guareschi Cazzullo, A | 1 |
| Musetti, L | 1 |
| Scarone, S | 1 |
1 trial available for pemoline and Anxiety Disorders
| Article | Year |
|---|---|
Effect of fluoxetine, pemoline and placebo on heart period and QT variability in normal humans.
Topics: Adult; Anxiety Disorders; Cardiac Output; Central Nervous System Stimulants; Death, Sudden, Cardiac; | 2003 |
2 other studies available for pemoline and Anxiety Disorders
| Article | Year |
|---|---|
Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.
Topics: Achievement; Adolescent; Amphetamine; Anxiety Disorders; Attention Deficit and Disruptive Behavior D | 2011 |
EEG and clinical findings during pemoline treatment in children and adults with attention deficit disorder. An 8-week open trial.
Topics: Adolescent; Adult; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Child; Depressi | 1984 |